2. • VADs have a paramount role
throughout the management of the
oncology patient
- in the initial phases for surgery or
chemotherapy,
- in the advanced stages for chronic
treatment,
- and in the last stages for palliative
measures.
3. • A central venous access device (CVAD) is made of a
non-irritant material, e.g; silicone, which means it
can be left in place for several weeks or months.
• It has a tip which lies at the junction of SVC & RA.
The other end has a hub or port for injection.
• It can be used to give fluids and drugs. It may also
be used to take blood samples.
• The CVAD will save the patient from having
repeated needle pricks from blood taking or
insertion of cannulas during treatment.
4. • Tunnelled central venous
catheter(Hickmann/ Broviac)
• Subcutaneous port (Port-a-
cath)
• Peripherally inserted central
catheter(PICC) or peripheral
access port (PAP)
7. • Ports have lower reported rates of
catheter-related bloodstream
infections.
• Best suited for long term
intermittent chemotherapy
• Ports allow better bathing and
swimming.
8. • An implanted port (sometimes called a
‘Portacath’) is inserted under the skin.
• The usual position is on the chest. It is
connected via a thin tube (catheter)
inserted into one of the IJV going to the
SVC . The port can be felt through the
skin.
• Entry to the port is gained by puncturing
the silicone membrane with a special
type of needle, which is attached to a
length of tubing
• This will allow to receive fluids and drugs
or have blood samples taken from it.
• Puncturing the port is similar to pricking
the skin with a pin. It takes some time
getting used to.
9.
10.
11. Advantages
• It only needs to have
the needle put in
when we need to use
it.
• The needle is
removed in between
treatments and there
is no need of any
dressings or flushing
the catheter.
• It doesn’t restrict
normal activities
including swimming.
Disadvantages
• A needle need to be
inserted each time the
port is used. The port can
sometimes be difficult to
access
• Insertion & removal of the
port needs GA & OT.
• Leaves a scar
• Cannot be accessed by
untrained staff.
12. Early Complications
(6.2% to 11.7%)
• Pneumothorax,
• Hemothorax,
• Primary
malposition,
• Arrhythmias,
• Air embolism,
• Arterial
perforation
LATE COMPLICATIONS
• Mechanical
complications (pinch
off, fractures,
dislodgement, or
migration);
• Extravasation injuries;
• Infections (including
phlebitis of the
cannulated vessel);
• Catheter and vein
thrombosis/
occlusion (including
deep vein
thrombosis,pulmonary
embolism, or SVC
syndrome)
13. • 2005-2017 = 11 years
• 118 ports
• 1-12months = 26
• 1year – 5 years = 63
• 5 year – 16 years = 24
• Adults = 5
18. • 5 year old boy with stage 4
Neuroblastoma
• Underwent biopsy with Autologous
bone marrow transplant.
• Port-a-cath was placed in right
internal jugular vein
• During last cycle of chemotherapy
mother noticed a bulge in chest wall
while injecting drug
• Admitted for port-a-cath removal
19. On exploration
• Port with only 5cms of catheter was found
• Distal end not palpable in jugular vein
• On table fluoroscopy was done
• Interventional cardiologist and radiologist
opinion sought
24. • Chemoports are very convenient for
patients undergoing long-term
chemotherapy.
• They can be accessed multiple times
with minimal pain.
• They have very low risk of
extravastation and blood stream
infection if handled properly.
• Though complications have been
described but negligible in
experienced hands.